Michael F. Press

The Ben May Laboratory for Cancer Research and the Department of Pathology, The University of Chicago, Chicago, IL 60637, U.S.A.

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers121 papers

Sort

By YearBy Citation

Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry

Zhaohui Du, Guimin Gao, Babatunde Adedokun,Thomas Ahearn,Kathryn L. Lunetta,Gary Zirpoli,Melissa Troester,Edward A. Ruiz-Narváez,Stephen Haddad,Jonine Figueroa,Esther M. John,Leslie Bernstein

Epidemiology, (2020): 2320-2320

Bibtex

Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers

Remi Klotz, Amal Thomas, Teng Teng, Sung Min Han, Oihana Iriondo, Lin Li, Sara Restrepo-Vassalli, Alan Wang, Negeen Izadian, Matthew MacKay, Byoung-San Moon, Kevin J Liu

CANCER DISCOVERY, no. 1 (2020): 86-103

WOSBibtex

Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial Profiler

Katherine Lee McNamara,Jennifer L. Caswell-Jin, Zhicheng Ma,Jason J. Zoeller, Michelle Kriner, Zoey Zhou, Jason Reeves, Margaret Hoang,Joseph Beechem,Dennis J. Slamon,Michael F. Press,Joan Brugge

CANCER RESEARCH, no. SUP4 (2020)

Bibtex

Breast Cancer Therapy Expert Group (BCTEG): A Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early Stage Breast Cancer

Muaiad Kittaneh,Sunil Badve, Humberto Caldera,Robert Coleman,Matthew P. Goetz,Reshma Mahtani,Eleftherios Mamounas,Kevin Kalinsky,Elyse Lower,Mark Pegram,Michael F. Press,Hope S. Rugo

Clinical Breast Cancer, no. 3 (2020): 183-193

Bibtex

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE

Stephen R D Johnston,Roberto Hegg,Seock-Ah Im,In Hae Park,Olga Burdaeva, Galina Kurteva,Michael F Press,Sergei Tjulandin,Hiroji Iwata, Sergio D Simon, Sarah Kenny,Severine Sarp

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, (2020)

WOSBibtex

Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial

Jennifer L. Caswell-Jin, Katherine L. McNamara,Judy Dering,Hsiao-Wang Chen, Robert Dichmann,Alejandra Perez,Ravindranath Patel, Eran Kotler,Jason J. Zoeller,Joan S. Brugge,Michael F. Press,Dennis J. Slamon

CANCER RESEARCH, no. SUP4 (2020)

Bibtex

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients

Ramona Erber,Matthias Rübner, Simon Davenport,Sven Hauke,Matthias W Beckmann,Arndt Hartmann,Lothar Häberle,Paul Gass,Michael F Press,Peter A Fasching

Breast cancer research and treatment, no. 2 (2020): 311-324

WOSBibtex

Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains

Nikhil Naik, Ali Madani, Andre Esteva, Nitish Shirish Keskar,Michael F Press,Daniel Ruderman,David B Agus,Richard Socher

Nature communications, no. 1 (2020): 5727-5727

WOSBibtex

Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer

Deborah L. Toppmeyer,Michael F. Press

Cancer Medicine, no. 18 (2020): 6463-6472

Bibtex

Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry

Babatunde Adedokun, Zhaohui Du, Guimin Gao,Thomas Ahearn,Kathryn L. Lunetta,Gary Zirpoli,Jonine Figueroa,Esther M. John,Leslie Bernstein,Wei Zheng,Jennifer J. Hu,Regina G. Ziegler

Epidemiology, (2020)

Bibtex

Abstract 4630: Eleven specific comorbidities and mortality risk in women diagnosed with invasive breast cancer between the ages of 35 and 64 years

Huiyan Ma,Giske Ursin,Kathleen E. Malone,Michael S. Simon,Jill A. McDonald,Brian L. Strom,Michael F. Press,Leslie Bernstein,Yani Lu

Epidemiology, (2020): 4630-4630

Bibtex

168PResults from TRIO030, a pre-surgical tissue-acquisition study to evaluate molecular alterations in human breast cancer tissue following short-term exposure to the androgen receptor antagonist darolutamide

H-W Chen, E Von Euw, P Millan, R Fresco, S Carrez, K Afenjar, H Fung, M Burton, A Santiago, R Guzman, I Villalobos,M Press

ANNALS OF ONCOLOGY, no. SUPnan (2019): 53-53

Bibtex

Role for polo-like kinase 4 in mediation of cytokinesis

Michael F Press, Bin Xie, Simon Davenport,Yu Zhou,Roberta Guzman,Garry P Nolan,Neil O'Brien, Michael Palazzolo,Tak W Mak,Joan S Brugge,Dennis J Slamon

Proceedings of the National Academy of Sciences of the United States of America, pp.201818820, (2019)

WOSBibtex

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy

Jennifer L Caswell-Jin, Katherine McNamara,Johannes G Reiter,Ruping Sun,Zheng Hu, Zhicheng Ma,Jie Ding,Carlos J Suarez, Susanne Tilk, Akshara Raghavendra, Victoria Forte,Suet-Feung Chin

Nature communications, no. 1 (2019): 657

Cited by11WOSBibtex

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

Michael F Press,Jose A Seoane,Christina Curtis,Emmanuel Quinaux,Roberta Guzman,Guido Sauter,Wolfgang Eiermann,John R Mackey,Nicholas Robert,Tadeusz Pienkowski,John Crown,Miguel Martin

JAMA ONCOLOGY, no. 3 (2019): 366.0-375

WOSBibtex

Potent cell cycle inhibition and upregulation of immune response with abemaciclib and anastrozole in neoMONARCH, Phase 2 neoadjuvant study in HR+/HER2- breast cancer

Sara A Hurvitz, Miguel Martín,Michael F Press, David Chan, Maria Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri,Chiun-Sheng Huang,Susana Barriga, Sameera R Wijayawardana, Manisha Brahmachary

Clinical cancer research : an official journal of the American Association for Cancer Research, (2019)

WOSBibtex

Abstract 2978: Clinical evaluation of lapatinib induced BCL-2 adaptive responses